HPV Vaccine: CDC Versus Israeli Health Ministry

Share Article

The Center for the Biology of Chronic Disease (CBCD) is amazed to discover the opposing views on the safety of the HPV vaccines held by the CDC and the Israeli Health Ministry. How is it possible that two teams of scientists would have views which are so far apart based on the same data?

News Image
Japan actually withdrew its recommendation for Gardasil vaccination back in June and now Israel is raising serious questions about the vaccine’s safety too. It makes one wonder why the CDC and FDA are renewing their push of Gardasil. - Greg Bennett, CBCD

The CBCD has learned about a new controversy. On the one hand, the CDC “is renewing its push to have more 11- and 12-year-old children of both sexes be vaccinated against cancer-causing strains of human papillomavirus (HPV), despite continuing concerns about its safety and opposition by many parents (1)” according to an article published on August 28, 2013 on Newsmax.com. On the other hand, the Israeli Health Ministry is re-evaluating the safety record of the HPV vaccine, according to a new article published in the Israeli newspaper, Haaretz on September 3rd, 2013 (2).

CDC spokeswoman Darlene M. Foote said, “Thousands of men and women die each year from HPV associated cancer. We now have a safe and effective vaccine that can prevent HPV infection. We owe it to our children to do all that we can to protect them so they can grow up to be healthy adults (1).”

In contrast, the doctors and medical researchers who turned to the Israeli Health Ministry with concerns about the HPV vaccine are regarded as some of the leading health professionals in Israel (2). “Health Ministry officials (in Israel) are considering canceling plans to administer the HPV vaccine to 52,000 eighth-grade girls, following studies suggesting vaccine-linked autoimmune conditions and other adverse effects (2).”

These studies are causing concern among experts in Israel’s much respected medical community. One such study was conducted by Israeli and Italian medical experts from Sheba Medical Center, Tel Hashomer, and Sapienza University of Rome. It was published in July 2013 in the American Journal of Reproductive Immunology (2).

The study described “patients who had adverse effects after being administered a vaccine against the human papilloma virus aimed at preventing infection with species of the virus associated with the development of cervical cancer (2).”

In fact, the authors wrote that there is “evidence of the potential of the HPV vaccine to trigger a life-disabling autoimmune condition.” They further wrote that “The increasing number of similar reports of post HPV vaccine-linked autoimmunity and the uncertainty of long-term clinical benefits of HPV vaccination are a matter of public health that warrants further rigorous inquiry (2).”

“Over the past year, governments around the world have begun expressing concern regarding the use of Gardasil. Japan actually withdrew its recommendation for Gardasil vaccination back in June (according to The Japan Times in an article published on June 15, 2013) (3), and now Israel is raising serious questions about the vaccine’s safety too. Thus, it makes one wonder why the CDC and FDA are renewing their push of Gardasil when health ministries in other countries are expressing serious concern in light of new information.” - Greg Bennett, CBCD

The Center believes that the poor safety record of the HPV vaccine is due to the fragments of foreign DNA contained in the vaccine. The CBCD suggests that these foreign DNA fragments could be a cause of the autoimmune conditions observed by the Israeli scientists, as suggested by Dr. Hanan Polansky’s Microcompetition with Foreign DNA Theory.

In fact, in September of 2012, the CBCD sent a letter to the offices of the FDA Commissioner, Dr. Margaret Hamburg, and to the offices of the CDC’s director, Dr. Thomas R. Frieden. This letter predicted the results of the studies by the Israeli scientists, and warned the FDA & CDC about the side effects reported in them.

The CBCD therefore calls on American health officials to follow the Israeli Health Ministry’s example and start its own re-evaluation of the HPV vaccines.

For more information on the Center for the Biology of Chronic Disease and the dangers posed by foreign DNA, visit http://www.cbcd.net. To request an interview or to speak with a CBCD official, please Email info (AT) CBCD (DOT) net.


(1)    http://www.newsmax.com/us/hpv-vaccines-cdc/2013/08/28/id/522720
(2)    http://www.haaretz.com/news/national/.premium-1.545014
(3)    http://www.japantimes.co.jp/news/2013/06/15/national/cervix-vaccine-issues-trigger-health-notice/#.Ui2EcNJkM_c


The CBCD is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Hanan Polansky
Center for the Biology of Chronic Disease (CBCD)
+1 (585) 250-9999
Email >
Visit website